FRCPC Eberhard L. Renner MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Patients with hepatocellular carcinoma (HCC) beyond the traditional criteria (advanced HCC) are typically offered palliation, which is associated with a 3-year survival rate lower than 30%. This study aimed to describe the outcomes for a subset of patients with advanced HCC who satisfied the Extended Toronto Criteria (ETC) and were listed for liver(More)
  • 1